MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
12.19
-0.14
-1.14%
After Hours: 12.43 +0.24 +1.97% 18:49 12/16 EST
OPEN
12.25
PREV CLOSE
12.33
HIGH
12.63
LOW
12.08
VOLUME
671.04K
TURNOVER
--
52 WEEK HIGH
13.41
52 WEEK LOW
4.020
MARKET CAP
640.22M
P/E (TTM)
9.42
1D
5D
1M
3M
1Y
5Y
1D
Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones · 17h ago
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target
Benzinga · 17h ago
Emergent BioSolutions Receives Buy Rating Amid Strategic Milestones and Strong Market Position
TipRanks · 18h ago
Weekly Report: what happened at EBS last week (1208-1212)?
Weekly Report · 1d ago
Emergent BioSolutions Gains FDA Approval for Winnipeg Facility
TipRanks · 4d ago
Emergent BioSolutions receives FDA approval for raxibacumab manufacturing
TipRanks · 4d ago
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
Barchart · 4d ago
Director Cashes In on Emergent Biosolutions Stock
TipRanks · 12/10 02:05
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.